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Abstract Galectins are a family of proteins involved in several
cell processes, including their survival and death. Galectin-3 has
in particular been described as an anti-apoptotic molecule
entangled with a number of subcellular activities including
anoikis resistance. In this work we partially address the
mechanisms underlying this activity pointing at two key factors
in injury progression: the alteration of mitochondrial membrane
potential and the formation of reactive oxygen species. Over-
expression of galectin-3 appears in fact to exert a protective
effect towards both these events. On the basis of these data, we
propose a reappraisal of the role of galectin-3 as a regulator of
mitochondrial homeostasis.
z 2000 Federation of European Biochemical Societies.
Key words: Galectin-3; Oxidative balance; Cell injury;
Cell death
1. Introduction
Galectins are a growing family of evolutionarily conserved
proteins widely distributed in nature from lower invertebrates
to mammals [1]. It is composed of at least 10 di¡erent mem-
bers [2]. Among them, galectin-3 was extensively studied. This
is a monomer with Mr 30 000 with a high a⁄nity for L-gal-
actosides mainly entangled in cell adhesion processes through
recognition of, and combination with, complementary glyco-
conjugates [3,4]. In addition, galectin-3 was also described as a
versatile multifunctional protein involved in multiple biologi-
cal processes including either cell growth or cell death [4]. In
fact, intracellular synthesis of galectin-3 is relevant to the pro-
liferation state [5] as well as to pre-mRNA splicing [6] or to
cell cycle and negative regulation of apoptotic mechanisms [7^
8]. More in general, galectin-3 appears to be involved in sev-
eral human pathologic processes including cancer as well as
infectious diseases. In fact, galectin-3, being involved in cell^
cell and cell^matrix interactions, has been proposed to play a
role in the pathogenic mechanisms of metastasis [9]. On the
other hand, a role for such a molecule has also been hypothe-
sized in the initial stages of the human immunode¢ciency
virus (HIV) infection process, most likely due to its activity
on the transport and/or splicing of HIV mRNA [10].
To address the role of galectin-3 in cell pathology, an ex-
perimental study on galectin-3 overexpressing cells has thus
been undertaken. We have studied the e¡ects of tumor ne-
crosis factor alpha (TNF-K), a cytokine which provokes re-
ceptor-mediated damage and apoptosis [11], and menadione, a
quinone able to induce necrosis by cell lysis [12]. Redox im-
balance is implicated in the mechanism of action of both
compounds [13,14]. Our results show that galectin-3 overex-
pression is able to protect the cells from injury and death
induced by both menadione and TNF-K by reducing intra-
cellular ROS generation and in£uencing mitochondrial mem-
brane potential (v8).
2. Materials and methods
2.1. Production and maintenance of stable galectin-3 transfectants
The human breast cancer cell line Evsa-T was obtained from Dr.
J.A. Foekens (Rotterdam, The Netherlands). Puri¢ed plasmid DNA
was used to transfect Evsa-T cells by the calcium phosphate method
as previously reported [15]. Two days after transfection, cells were
selected by culturing them in the presence of 1 mg/ml of G418 for
at least 2 weeks. Di¡erent clones were maintained at 37‡C in Dulbec-
co’s modi¢ed Eagle’s medium containing 2% glutamine, 10% fetal calf
serum and antibiotics (Flow, Irvine, UK). Three of these clones,
termed EV-M13, EV-M5 and EV-M10, were selected. The expression
of galectin-3 in the EV-M13 clone, as well as in Evsa-T parental cells,
was very low. By contrast, clone EV-M10 expressed high levels of this
lectin [15]. We, thus, decided to use EV-M13 cells as appropriate
controls. Moreover, the EV-M5 clone expressing intermediate levels
of galectin-3 also displayed an intermediate ‘behavior’ with respect to
other cell clones considered. Hence, these results, although of impor-
tance, have been omitted.
2.2. Cell treatments
2.2.1. Menadione treatments. The culture medium was changed
with a bu¡er solution (phosphate-bu¡ered saline containing 1 mM
MgCl2 and CaCl2, pH 7.3) and the cells were treated with 200 WM
menadione (Sigma, St. Louis, MO, USA) diluted in dimethylsulfoxide
(DMSO, Sigma). Cells treated with an equal volume of DMSO for the
same period of time but without menadione, were considered as con-
trols.
2.2.2. TNF-K treatments. Cells were exposed to sequential treat-
ment of 4 mM cycloheximide (CHX, Sigma) for 2 h followed by 50 IU
TNF-K (Sigma, ¢nal puritys 95%) as previously described [11].
For qualitative and quantitative studies of cell injury and death, cell
treatments were performed for 4 h. For the analysis of early events
(v8, reactive oxygen species (ROS) evaluation and glutathione (GSH)
intracellular levels) treatments were performed for 3 h.
2.3. Scanning electron microscopy (SEM)
Control and treated cells were ¢xed with 2.5% glutaraldehyde in 0.1
M cacodylate bu¡er (pH 7.4) at room temperature for 20 min. Fol-
lowing post ¢xation in 1% OsO4 for 30 min, cells were dehydrated
through graded ethanols, critical point dried in CO2 and gold coated
by sputtering. The samples were examined with a Cambridge 360
scanning electron microscope.
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 5 4 7 - 7
*Corresponding author. Fax: (39)-6-493 87 140.
E-mail: malorni@mclink.it
FEBS 23679 11-5-00 Cyaan Magenta Geel Zwart
FEBS 23679 FEBS Letters 473 (2000) 311^315
2.4. Evaluation of apoptosis and necrosis
Both untreated and treated cells were harvested, washed and double
stained by using an annexin V-FITC apoptosis detection kit (Eppen-
dorf s.r.l., Mi, Italy). This kit is based on the observation that soon
after initiating apoptosis most cell types translocate the membrane
phospholipid phosphatidylserine (PS) from the inner face of the plas-
ma membrane to the cell surface. Annexin V has a strong Ca2 de-
pendent a⁄nity for PS and therefore serves as a probe for detecting
apoptosis. Cells which have lost membrane integrity (therefore con-
sidered as necrotic cells) will show red staining (PI) throughout the
nucleus and therefore will be easily distinguishable from the apoptotic
cells. Samples were incubated for 10 min in the dark with annexin V
and PI (40 Wg/ml).
2.5. Measurements of intracellular ROS
Cells (5U105) were incubated in 490 Wl of Hanks balanced salt
solution (HBSS, pH 7.4) with 5 Wl of hydroetidine (HE, Molecular
Probes, Eugene, OR, USA) or dihydrorhodamine 123 (DHR 123,
Molecular Probes) in polypropylene test tubes for 5 min at 37‡C
[16]. The ¢nal concentration of HE and DHR 123 were 1 and
10 WM, respectively. HE is a chemically reduced ethidium derivative.
It is a non-£uorescent membrane-permeable dye that can be oxidized
directly to the red £uorescent ethidium bromide by O2 generated in-
side the cells after di¡erent treatments. DHR 123 is a dye freely
di¡using into cells, oxidized primarily by H2O2 in a myeloperoxidase
dependent reaction to green £uorescence [17]. As DHR 123 is accu-
mulated by mitochondria, we excluded possible interference in ROS
evaluation by using carbonyl cyanide p-(tri£uoro-methoxy) phenylhy-
drazone (FCCP, 20 WM Sigma) a protonophore able to depolarize
mitochondrial membrane, as previously described [18]. Furthermore,
according to literature data [19] we also con¢rmed the results con-
cerning H2O2 production by using 2P,7P-dichloro-dihydro£uorescein
diacetate (H2DCFDA, Molecular Probes).
To exclude PI-positive cells from the analysis of H2O2 production
we performed a double staining procedure by using H2DCFDA/PI,
whereas, to estimate the percentage of dead cells in samples stained
with HE (which emits in FL2 channel like PI) we incubated parallel
tubes with PI for 15 min at 37‡C. However, in consideration of the
low rate of dead cells (between 3 and 5%), these data will not be
discussed further.
2.6. Determination of total intracellular GSH levels
Intracellular GSH content was evaluated by using 5-chloromethyl-
2P,7P-dichloro-dihydro£uorescein diacetate (CM-H2DCFDA, Molecu-
lar Probes). CM-H2DCFDA passively di¡uses into living cells, where
its acetate groups are cleaved by intracellular esterases and its thiol-
reactive chloromethyl group reacts with intracellular GSH. Subse-
quent oxidation yields a £uorescent adduct that is trapped inside
the cells. Untreated and treated cells (5U105) were incubated with
10 WM of CM-H2DCFDA for 15 min at 37‡C in HBSS supplemented
with 5 mg/ml of bovine serum albumin. Cells exposed to L-buthionine-
[S,R]-sulfoximine, 7.5 WM (Sigma), a GSH depleting drug, for 16 h
were considered as negative controls. PI-positive cells were excluded
from our analysis.
2.7. v8
The v8 of control and treated Evsa-T cells was studied by using the
probe JC-1. According to the method, cells were stained with 10 Wg/ml
of 5,5P,6,6P-tetrachloro-1,1P,3,3P-tetraethylbenzimidazol-carbocyanine
iodide (JC-1, Molecular Probes). JC-1 is a metachromatic probe
able to enter the mitochondria selectively. It exists in a monomeric
form (in the green channel, FL1) but, depending on the membrane
potential, JC-1 can form J-aggregates that are associated with a large
shift in the emission range (in the orange channel, FL2) [11]. JC-1 is
both qualitative (considering the shift from green to orange) and
quantitative (considering the ‘pure’ £uorescence intensity). As a meth-
odological control, cells were treated with increasing concentrations
(from 0.1 to 10 Wg/ml) of K ionophore valinomycin (Sigma) which
dissipates v8 but not pH gradient. To verify cell viability parallel
tubes were incubated with PI for 15 min at 37‡C before analyses.
2.8. Data analysis and statistics
All samples were washed, cooled on an ice bath and immediately
analyzed on a FACScan £ow cytometer (Becton Dickinson, Mountain
View, CA, USA) equipped with a 488 argon laser. At least 20 000
events have been acquired. Data were recorded and statistically ana-
lyzed by a Hewlett Packard computer using the Lysys II Software. All
data reported are the mean of four separate experiments þ S.D. Stat-
istical analysis was performed by using Student’s t-test. Concerning
£ow cytometry experiments, calculation of the £uorescence was car-
ried out after the conversion of logarithmically ampli¢ed signals into
values on a linear scale and the statistical signi¢cance was calculated
by using the parametric Kolmogorov^Smirnov (K/S) test or non-para-
metric tests to analyze unimodal or bimodal curves, respectively. Only
P values of less than 0.01 were considered as signi¢cant.
3. Results
3.1. Cell injury analysis
We have recently reported that galectin-3 overexpression is
able to protect Evsa-T cells from apoptotic injury [15]. In this
work we compared the e¡ects of two di¡erent experimental
toxins (TNF-K and menadione) by considering (i) v8 and (ii)
by evaluating some parameters indicative of the redox state of
the cells, i.e. ROS generation and GSH content. TNF-K is a
cytokine which provokes receptor-mediated apoptosis while
menadione is a superoxide producing quinone mainly induc-
ing necrosis [11,14]. In Fig. 1a^f qualitative^descriptive anal-
yses of this phenomenon performed by SEM are reported.
With respect to controls (Fig. 3a,b), cells exposed to both
CHX/TNF-K (Fig. 1c,d) or menadione (Fig. 1e,f) showed
the typical sequence of changes ¢nally resulting in cell detach-
ment and death. However, although similar in principle, re-
markable di¡erences were detected between the two cell
clones. In fact, cell retraction, rounding, blebbing and, ¢nally,
detachment from the substrate (not shown) were easily de-
tected in EV-M13 cells (Fig. 1a,c,e; left panel) while these
alterations were only partially visible in the EV-M10 clone
(Fig. 1b,d,f; right panel). In these cells, expressing high levels
of galectin-3, stable cell^cell and cell^substrate interactions
were in fact maintained without any sign of rounding or de-
tachment (Fig. 1d,f). For a quantitative evaluation of this
phenomenon, a cytometric analysis of cells double stained
with annexin V-FITC/PI to distinguish apoptosis from ne-
crosis, was then performed (Fig. 1g). In fact, con¢rming
SEM observations, the EV-M13 clone (low levels of galec-
tin-3), with respect to the EV-M10 clone (overexpressing ga-
lectin-3), underwent signi¢cantly higher (P6 0.01) rates of
apoptotic (annexin V single positive) as well as of necrotic
(annexin V/PI double positive) cell death after both CHX/
TNF-K and menadione.
3.2. v8
In view of the importance of mitochondrial integrity in the
apoptotic as well as in the necrotic cell death process, speci¢c
analyses on v8 by using a JC-1 probe were carried out. In
particular, we performed a £ow cytometry study to verify the
possible in£uence of galectin-3 expression on mitochondrial
homeostasis. As a positive control of this series of experiments
we used the same cell lines (EV-M13 and EV-M10) treated
with di¡erent concentrations (0.1, 1 and 10 Wg/ml) of K
ionophore valinomycin as speci¢ed in Section 2. According
to literature data [11], we observed a dose dependent decrease
of FL2 signals. In particular, we revealed 60 þ 7%, 75 þ 5%
and 89 þ 4% of cells with depolarized mitochondria after
0.1, 1 and 10 Wg/ml valinomycin exposure, respectively. After
both TNF-K and menadione treatments, the EV-M13 clone
(left panel) showed a marked decrease in mitochondrial mem-
brane polarization. This is represented by the alteration of the
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contour plot as shown in Fig. 3c,e, respectively. In fact, ac-
cording to the above method, the cells with depolarized mi-
tochondria are those moving from quadrant I to quadrant II
as they lose greenish orange £uorescence (in FL2). This e¡ect
was consistently reduced in the EV-M10 clone (right panel),
which expresses a high level of galectin-3, after both TNF-K
(Fig. 3d) and menadione (Fig. 3f) administration. By contrast,
v8 of EV-M13 and EV-M10 untreated cells were comparable
(Fig. 2a,b). Accordingly, quantitative evaluation of the per-
centage of cells with depolarized mitochondria indicated a
signi¢cant di¡erence between the two cell clones (P6 0.01,
Fig. 3g).
3.3. Redox balance
Mitochondrial membrane depolarization has been reported
to enhance the generation superoxide anion in a number of
cells [20]. In turn, these products are implicated in the initia-
tion of both necrosis and apoptosis. In light of this, we per-
Fig. 1. Qualitative (a^f) and quantitative (g) analysis of cell injury. Scanning electron micrographs showing: (a) EV-M13 and (b) EV-M10 con-
trol cells ; (c) EV-M13 and (d) EV-M10 cells treated with CHX/TNF-K ; (e) EV-M13 and (f) EV-M10 cells treated with menadione. Magni¢ca-
tion 2700U. (g) Quanti¢cation of necrosis and apoptosis of cells double stained with annexin V-FITC/PI. * in (g) indicates P6 0.01.
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formed a £ow cytometry analysis to investigate the ROS gen-
eration in our clones after both TNF-K (Fig. 3a^c, left panel)
and menadione (Fig. 3d^f, right panel) addition by using HE
and DHR 123 as £uorogenic substrates. These probes are
penetrating cations which are accumulated by mitochondria.
To exclude the possibility that v8 could obscurate the mon-
itoring of ROS, we performed these experiment both in the
presence or absence of FCCP protonophore as reported in
Section 2. The production of O2 and H2O2 was signi¢cantly
increased after treatment with both TNF-K (Fig. 3a,b) and
menadione (Fig. 3d,e) but not after FCCP addition (not
shown) in both cell lines. However, as clearly shown in Fig.
3, this increase was more evident in the EV-M13 clone, ex-
pressing low levels of galectin-3, with respect to EV-M10 cells
expressing high levels of this lectin. This di¡erence between
EV-M13 (full lines) and EV-M10 (dashed lines) clones was
highly signi¢cant (P6 0.01) for both O2 and H2O2. It is im-
portant to note the correspondence between the increased
ROS production and the proportional decrease of v8 (Fig. 2).
Since the role of GSH depletion in cell injury is well known
[21], intracellular reduced GSH in living cells was also eval-
uated by £ow cytometry analysis. We found that intracellular
levels of GSH were strongly reduced in EV-M13 cells treated
with menadione as well as with TNF-K (Fig. 3c,f, respectively,
full lines). By contrast, this reduction was signi¢cantly
(P6 0.01) less pronounced in EV-M10 cells, expressing high
levels of galectin-3 (Fig. 3c,f, respectively, dashed lines). Fur-
thermore, after TNF-K treatment, additional alterations were
appreciated. In fact, two distinct cell sub-populations contain-
ing di¡erent levels of GSH, in both EV-M13 (full line) and
EV-M10 (dashed line) clones, as indicated by bimodal curves,
were detected (Fig. 3c). In particular, in the TNF-K-treated
EV-M13 clone, one of these cell sub-populations (see arrow in
Fig. 3c) showed a dramatic reduction in the intracellular GSH
levels (similar to that observed in necrotic cells, see arrow in
Fig. 3f). This cell sub-population, being PI-positive dead cells
excluded from our analysis, has to be considered in the late
phases of apoptosis.
4. Discussion
As a general rule, there are con£icting reports describing
the biological role of galectins, e.g. their pro- and anti-apo-
ptotic activity. In particular, several reports indicated that
galectin-3, probably the most studied of these lectins, can
prevent zww cell death in human cells of di¡erent histotypes
[7,15,20]. The anti-apoptotic e¡ect of galectin-3 appeared to
result from the ability of this molecule to heterodimerize with
bcl-2, a well known suppressor of apoptosis [22]. In addition,
very recent works point out that transfection of galectin-3
cDNA in human breast carcinoma cells can confer anoikis-
resistance acting on cell cycle progression [7] and increasing
integrin dependent adhesion capability [15]. In particular, we
reported that the apoptotic phenomenon induced by ultravio-
let radiation B (UVB) or by TNF-K in Evsa-T cells can be
counteracted by overexpression of galectin-3 [15]. Since both
Fig. 2. Cyto£uorimetric analysis of v8. Left panel, EV-M13 cells;
right panel, EV-M10 cells. Abscissa, FL1 (green £uorescence, log
scale); ordinate, FL2 (orange £uorescence, log scale). In quadrant
II, cells with depolarized mitochondria. A representative of four ex-
periments is shown in (a)^(f). Quanti¢cation of data concerning
four di¡erent experiments is reported in (g). * indicates P6 0.01.
Fig. 3. Cyto£uorimetric analysis of superoxide and peroxide produc-
tion and GSH content in living cells. On the abscissa the £uores-
cence intensity (log. scale) is reported; on the ordinata, the relative
cell number. Full lines represent the EV-M13 clone, dashed lines
represent the EV-M10 clone. A representative of four experiments is
shown.
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UVB and TNF-K can induce oxidative imbalance [13,23], we
hypothesized that galectin-3 could interfere with ROS gener-
ation. In fact, in the present work we partially address this
point by considering two di¡erent stimuli whose mechanism
of action implicates di¡erent redox alterations: TNF-K and
menadione. Our data revealed that ROS generation induced
by these treatments was signi¢cantly prevented by overexpres-
sion of galectin-3. This e¡ect was consistent with the inhibi-
tion of cell death o¡ered by the overexpression of this lectin
independently from the mode of cell death, i.e. by apoptosis
or necrosis. Both of these include in fact an oxidative imbal-
ance as the mandatory mechanism. This suggests that galec-
tin-3 might interfere with very early stages of cell death that
are associated with perturbation of mitochondrial homeostasis
and subsequent formation of ROS and GSH depletion. This is
evinced by the fact that EV-M10 cells, expressing high levels
of galectin-3 and ‘preserved’ v8, after TNF-K and menadione
treatments, displayed decreased ROS generation and higher
levels of thiols, with respect to EV-M13 clone. Furthermore,
considering the signi¢cant sequence similarity with bcl-2 [22]
and the close relationships between bcl-2 and mitochondria in
apoptosis progression [24], the present data represent the ¢rst
indication that galectin-3 could be an additional mitochon-
drial-associated apoptotic regulator.
The results reported here also suggest a more general role
exerted by galectins in certain pathologic conditions, including
infectious and non-infectious diseases. For instance, Tat pro-
tein from HIV, an essential pro-oxidant molecule involved in
viral replication [25], is capable of inducing an overexpression
of galectin-3 [10]. From a ¢nal point of view, this could be
exerted by a direct action on mitochondria as well as on ROS
formation, leading to the hindering of infected cell suicide and
allowing viral production. On the other hand, a role for ga-
lectins in non-infectious disease, i.e. tumor progression, has
also been proposed [1]. Particularly, increased galectin-3 ex-
pression in more invasive tumor cells has been demonstrated,
e.g. in colon carcinoma [26]. This increase could favor cell
survival and subsequently, thanks to its demonstrated e¡ect
on cytoskeleton [15,27], tumor cell spreading. Moreover, in
the same vein, we cannot rule out the possibility that the
increased cell resistance to oxidative imbalance due to galec-
tin-3 overexpression could lead to an increased resistance to-
wards certain chemotherapic drugs which exert their activity
by modifying the redox state of the cells. As a general rule, on
the basis of our results, we can hypothesize that galectin-3, by
in£uencing mitochondrial homeostasis, can speci¢cally inter-
fere with redox pathways controlling cell survival and death,
playing a role in the pathogenesis of several diseases.
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